Application of berberine or derivatives thereof in preparation of myocardial perfusion imaging agent
The 18F-labeled berberine derivative solves the problems of the short half-life of the PET myocardial perfusion imaging agent nuclide and the inability to perform exercise stress imaging, and achieves the effect of high affinity and long-term maintenance of high radioactivity distribution in myocardial cells. , providing a new PET myocardial perfusion imaging agent suitable for clinical application.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0040] Example 1 Preparation of 18F-labeled berberine derivatives of the present invention
[0041] 18F labeled berberine derivatives of the present invention (named as [ 18 F] HX-01) is provided by the Department of Nuclear Medicine, West China Hospital, Sichuan University, and can also be synthesized according to the patented method with the notification number CN 102989017B.
[0042] [ 19 F] HX-01: 18F-labeled berberine derivative non-radioactive reference substance, synthesized according to the patented method with the notification number CN102989017 B.
[0043] The beneficial effect of the present invention is specified below by test example:
PUM
| Property | Measurement | Unit |
|---|---|---|
| half-life | aaaaa | aaaaa |
| half-life | aaaaa | aaaaa |
| half-life | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More - R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com